Trial Profile
A Non-Randomized Phase II Study of Sequential Irinotecan (CPT-11) And Flavopiridol In Patients With Advanced Hepatoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2013
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary) ; Irinotecan (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 15 Aug 2005 New trial record.